Pharma4ever QA ApS: Financial statements 2024
CVR: 39104644
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma4ever QA ApS (CVR 39104644) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 11,494,444 and a net result of DKK 2,507,255 compared with DKK 1,727,927 the year before. That is an increase of 33.4% compared with the year before. Equity in the 2024 report amounted to DKK 2,557,256. The solvency ratio was 62.2%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 11,494,444
- Profit/Loss
- DKK 2,507,255
- Equity
- DKK 2,557,256
- Total Assets
- DKK 4,109,687
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 11.5 mio. | 2.5 mio. | 2.6 mio. | 8 |
| 2023 | - | 8.6 mio. | 1.7 mio. | 1.8 mio. | 6 |
| 2022 | - | 7.7 mio. | 2 mio. | 2.1 mio. | 5 |
| 2021 | - | 5.9 mio. | 1.3 mio. | 1.3 mio. | 5 |
| 2020 | - | 6 mio. | 1.6 mio. | 1.7 mio. | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of November 1, 2024, RevisorGården Holbæk A/S has been appointed auditor of Pharma4ever QA ApS.
As of October 31, 2024, RGH af 1. november 2024 A/S has stepped down as auditor of Pharma4ever QA ApS.
Pharma4ever QA ApS has published its annual report for 2023. Gross profit came to DKK 8,616,787, and the net result was DKK 1,727,927.
About Pharma4ever QA ApS
Pharma4ever QA ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2017. The company is under bankruptcy. The company is registered under the industry Anden teknisk rådgivning. The company is owned by BHP Holding ApS, Andresen Holding af 29. maj 2015 ApS and SLP Holding 2017 ApS. The company has 3 employees (2018). In 2024, the company reported a gross profit of DKK 11,494,444 and a net result of DKK 2,507,255 compared with DKK 1,727,927 the year before. Equity in the 2024 report amounted to DKK 2,557,256.